A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.

MLA

Ceribelli, Michele, et al. “A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.” Cancer Cell, vol. 30, no. 5, Nov. 2016, pp. 764–78. EBSCOhost, https://doi.org/10.1016/j.ccell.2016.10.002.

APA

Ceribelli, M., Hou, Z. E., Kelly, P. N., Huang, D. W., Wright, G., Ganapathi, K., Evbuomwan, M. O., Pittaluga, S., Shaffer, A. L., Marcucci, G., Forman, S. J., Xiao, W., Guha, R., Zhang, X., Ferrer, M., Chaperot, L., Plumas, J., Jaffe, E. S., Thomas, C. J., & Reizis, B. (2016). A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancer Cell, 30(5), 764–778. https://doi.org/10.1016/j.ccell.2016.10.002

Chicago

Ceribelli, Michele, Zhiying Esther Hou, Priscilla N. Kelly, Da Wei Huang, George Wright, Karthik Ganapathi, Moses O. Evbuomwan, et al. 2016. “A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm.” Cancer Cell 30 (5): 764–78. doi:10.1016/j.ccell.2016.10.002.